Closed-End Fund Advisors’s Amgen AMGN Stock Holding History

Closed-End Fund Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Hold	800	–	–	0.28%	105
2026 Q1	$281K	Hold	800	–	–	0.29%	103
2025 Q4	$262K	Buy	+800	New	+$254K	0.15%	115

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Closed-End Fund Advisors's AMGN Position: Q2 2026 in Review

Closed-End Fund Advisors held its Amgen (AMGN) position steady in Q2 2026 at 800 shares worth $290K. The position accounts for 0.28% of the portfolio, ranked #105.

Closed-End Fund Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Closed-End Fund Advisors held 800 shares of Amgen worth $290K as of Q2 2026.
Closed-End Fund Advisors left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.28% of Closed-End Fund Advisors's portfolio in Q2 2026, its #105 holding.
Closed-End Fund Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Closed-End Fund Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.